Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women: A Randomized Double-Blind, Placebo-Controlled Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06508944
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:35.812910+00:00
Published At
2025-04-20T00:00:00+00:00
Record Updated At
2025-04-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Lower Urinary Tract Symptoms", "Female Genitourinary Disease", "Urinary Stress Incontinence", "Urinary Urge Incontinence", "Nocturia", "Quality of Life", "Voiding Disorders", "Vagina Atrophy", "Urethral Atrophy", "Overactive Bladder", "Overactive Bladder Syndrome", "Bladder, Overactive"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-04-20"
protocolSection.identificationModule.nctId
"NCT06508944"
protocolSection.identificationModule.officialTitle
"Efficacy of Vaginal 17\u03b2-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women: A Randomized Double-Blind, Placebo-Controlled Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Lower Urinary Tract Symptoms (protocolSection.conditionsModule.conditions)
  • Female Genitourinary Disease (protocolSection.conditionsModule.conditions)
  • Urinary Stress Incontinence (protocolSection.conditionsModule.conditions)
  • Urinary Urge Incontinence (protocolSection.conditionsModule.conditions)
  • Nocturia (protocolSection.conditionsModule.conditions)
  • Quality of Life (protocolSection.conditionsModule.conditions)
  • Voiding Disorders (protocolSection.conditionsModule.conditions)
  • Vagina Atrophy (protocolSection.conditionsModule.conditions)
  • Urethral Atrophy (protocolSection.conditionsModule.conditions)
  • Overactive Bladder (protocolSection.conditionsModule.conditions)
  • Overactive Bladder Syndrome (protocolSection.conditionsModule.conditions)
  • Bladder, Overactive (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.